Christopher Doyle, PhD, Senior Director of IBC Services at WCG provides an overview of common approaches, emerging trends, and future prospects of gene therapies for inherited retinal disorders. Inherited retinal disorders (IRDs) are a group of genetically diverse conditions that lead to significant vision impairment and often culminate in complete blindness. Affecting approximately one in […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!